[8-K] ELI LILLY & Co Reports Material Event

Rhea-AI Filing Summary

Eli Lilly and Company furnished an 8-K under Item 2.02 to announce it issued a press release with financial results for the quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 and is incorporated by reference into Item 2.02.

The information in Item 2.02 is being furnished and is not deemed filed for purposes of Section 18 of the Exchange Act. The filing also includes Exhibit 104 for the cover page Inline XBRL. The document identifies Lilly’s listed securities, including common stock (LLY) on the NYSE.

0000059478false00000594782025-10-302025-10-300000059478us-gaap:CommonClassAMember2025-10-302025-10-300000059478lly:A1.625NotesDueJune22026Member2025-10-302025-10-300000059478lly:A2.125NotesDueJune32030Member2025-10-302025-10-300000059478lly:A625Notesdue2031Member2025-10-302025-10-300000059478lly:A500NotesDue2033Member2025-10-302025-10-300000059478lly:A6.77NotesDueJanuary12036Member2025-10-302025-10-300000059478lly:A1625NotesDue2043Member2025-10-302025-10-300000059478lly:A1.700Notesdue2049Member2025-10-302025-10-300000059478lly:A1125NotesDue2051Member2025-10-302025-10-300000059478lly:A1375NotesDue2061Member2025-10-302025-10-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): October 30, 2025

ELI LILLY AND COMPANY

(Exact Name of Registrant as Specified in its Charter) 

Indiana

001-06351

35-0470950

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

Lilly Corporate Center

Indianapolis,

Indiana

46285

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (317) 276-2000

Not Applicable

(Former Name or Former Address, if Changed Since Last Report.) 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock (no par value)

LLY

New York Stock Exchange

1.625% Notes due 2026

LLY26

New York Stock Exchange

2.125% Notes due 2030

LLY30

New York Stock Exchange

0.625% Notes due 2031

LLY31

New York Stock Exchange

0.500% Notes due 2033

LLY33

New York Stock Exchange

6.77% Notes due 2036

LLY36

New York Stock Exchange

1.625% Notes due 2043

LLY43

New York Stock Exchange

1.700% Notes due 2049

LLY49A

New York Stock Exchange

1.125% Notes due 2051

LLY51

New York Stock Exchange

1.375% Notes due 2061

LLY61

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.

Attached hereto as Exhibit 99.1 and incorporated by reference into this Item 2.02 is a copy of the press release, dated October 30, 2025, announcing the financial results of Eli Lilly and Company for the quarter ended September 30, 2025.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.			Description
99.1			Press Release of Eli Lilly and Company, dated October 30, 2025.
104			Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ELI LILLY AND COMPANY
(Registrant)
By:						/s/ Donald A. Zakrowski
Name:						Donald A. Zakrowski
Title:						Senior Vice President, Finance, and Chief Accounting Officer
Date:						October 30, 2025

FAQ

What did LLY disclose in this 8-K?

LLY furnished Item 2.02 to provide a press release announcing financial results for the quarter ended September 30, 2025, attached as Exhibit 99.1.

Is the earnings information considered filed or furnished?

The Item 2.02 information is furnished and is not deemed filed under Section 18 of the Exchange Act.

Which exhibits are included with the 8-K?

The filing includes Exhibit 99.1 (press release) and Exhibit 104 (Cover Page Inline XBRL data file).

What period does the press release cover?

It covers financial results for the quarter ended September 30, 2025.

Who signed the report for LLY?

It was signed by Donald A. Zakrowski, Senior Vice President, Finance, and Chief Accounting Officer.

On which exchange is LLY common stock listed?

LLY common stock is listed on the New York Stock Exchange under the symbol LLY.